Ver ítem 
    •   Inicio
    • INPRF
    • Artículos de revista
    • Ver ítem
    •   Inicio
    • INPRF
    • Artículos de revista
    • Ver ítem
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Evaluating the drug use "gateway" theory using cross-national data: Consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys

    Thumbnail
    Metadatos
    Mostrar el registro completo del ítem
    Resumen
    Background: It is unclear whether the normative sequence of drug use initiation, beginning with tobacco and alcohol, progressing to cannabis and then other illicit drugs, is due to causal effects of specific earlier drug use promoting progression, or to influences of other variables such as drug availability and attitudes. One way to investigate this is to see whether risk of later drug use in the sequence, conditional on use of drugs earlier in the sequence, changes according to time-space variation in use prevalence. We compared patterns and order of initiation of alcohol, tobacco, cannabis, and other illicit drug use across 17 countries with a wide range of drug use prevalence. Method: Analyses used data from World Health Organization (WHO) World Mental Health (WMH) Surveys, a series of parallel community epidemiological surveys using the same instruments and field procedures carried out in 17 countries throughout the world. Results: Initiation of "gateway" substances (i.e. alcohol, tobacco and cannabis) was differentially associated with subsequent onset of other illicit drug use based on background prevalence of gateway substance use. Cross-country differences in substance use prevalence also corresponded to differences in the likelihood of individuals reporting a non-normative sequence of substance initiation. Conclusion: These results suggest the "gateway" pattern at least partially reflects unmeasured common causes rather than causal effects of specific drugs on subsequent use of others. This implies that successful efforts to prevent use of specific "gateway" drugs may not in themselves lead to major reductions in the use of later drugs. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
    URI
    http://repositorio.inprf.gob.mx/handle/123456789/5335
    https://doi.org/10.1016/j.drugalcdep.2009.12.001
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835832/
    Colecciones
    • Artículos de revista
    Fecha
    2010
    Autor
    Degenhardt, Louisa
    Dierker, Lisa
    Chiu, Wai Tat
    Medina-Mora, María Elena
    Neumark, Yehuda
    Sampson, Nancy
    Alonso, Jordi
    Angermeyer, Matthias
    Anthony, James C.
    Bruffaerts, Ronny
    De Girolamo, Giovanni
    De Graaf, Ron
    Gureje, Oye
    Karam, Aimee N.
    Kostyuchenko, Stanislav
    Lee, Sing
    Lepine, Jean-Pierre
    Levinson, Daphna
    Nakamura, Yosikazu
    Posada-Villa, José
    Stein, Dan
    Wells, J. Elisabeth
    Kessler, Ronald C.
    Nivel de acceso
    acceso cerrado
    Nombre de la Rev. [SO]
    Drug and alcohol dependence
    Publisher
    ELSEVIER IRELAND LTD, ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND
    Volumen [VL], Número [SU], Paginación [PG]
    108 (1-2) 84-97 p.
     
    versión del editor
     
    Idioma [LA]
    eng
    Tipo de documento [TP]
    article
    DOI [DO]
    10.1016/j.drugalcdep.2009.12.001   

    DSpace software copyright © 2002-2015  DuraSpace
    Contacto | Sugerencias
     

     

    Mi cuenta

    AccederRegistro

    Listar

    Todo DSpaceComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosMateriasEsta colecciónPor fecha de publicaciónAutoresTítulosMaterias

    DSpace software copyright © 2002-2015  DuraSpace
    Contacto | Sugerencias